Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 482.50 GBp
Change Today +12.50 / 2.66%
Volume 25.0
As of 11:35 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

imperial innovations group p (IVO) Snapshot

482.50 GBp
Previous Close
470.00 GBp
Day High
482.50 GBp
Day Low
482.50 GBp
52 Week High
08/14/15 - 540.00 GBp
52 Week Low
10/10/14 - 425.00 GBp
Market Cap
Average Volume 10 Days
-0.02 GBp
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

imperial innovations group p (IVO) Related Businessweek News

No Related Businessweek News Found

imperial innovations group p (IVO) Details

Imperial Innovations Group plc is a venture capital and private equity firm specializing in all stages of development including incubation, seed, early stage, growth capital, development funding, and later stage investments. The firm typically invests in all sectors. It focuses on technology, all-things-saas (software-as-a-service), analytics, security, bioengineering, therapeutics, software, hardware, healthcare, medical devices, and diagnostics, energy, engineering, materials, clean tech, digital, environment, and bioscience companies founded by or based on technology and intellectual property from the University of Oxford, the University of Cambridge, Imperial College, and University College, London. It primarily invests in companies based in the United Kingdom. The firm typically invests between £0.02 million ($0.03 million) and £1 million ($1.71 million). It also invests between £1 million ($1.71 million) and £5 million ($8.55 million) and further between £5 million ($8.55 million) and above £25 million ($42.76 million) for stake building purposes. The firm prefers to lead or co-lead its investments. It also makes subsequent funding technology rounds working in partnership with founders, management, and co-investors. The firm seeks to take a board seat on its portfolio companies. It also provides technology transfer services and targets companies based on the intellectual property from Imperial College. Imperial Innovations Group plc was founded in 1986 and is based in London, the United Kingdom with an additional office in Cambridge, United Kingdom.

64 Employees
Last Reported Date: 11/12/14
Founded in 1986

imperial innovations group p (IVO) Top Compensated Officers

Chief Executive Officer, Executive Director a...
Total Annual Compensation: 403.0K GBP
Managing Director of Technology Transfer Offi...
Total Annual Compensation: 135.0K GBP
Chief Investment Officer, Director, and Membe...
Total Annual Compensation: 352.0K GBP
Compensation as of Fiscal Year 2014.

imperial innovations group p (IVO) Key Developments

Imperial Innovations Group plc Announces Resignation of Non-Executive Director Mark Rowan, Effective 31 July 2015

Imperial Innovations Group plc announced that its non-executive director Mark Rowan will resign from the Board on 31 July 2015.

Imperial Innovations Group plc Enters into £50 Million Loan Facility from EIB

Imperial Innovations Group plc has entered into another loan facility from the European Investment Bank (EIB) to support Innovation's investments in the UK biotech and life science sector. The £50 million committed loan facility is available for draw down over a period of two years and is repayable over a maximum of nine years following the date of the first draw down. This is the second facility that Innovations has secured from the EIB and follows a £30 million loan agreed in July 2013.

Imperial Innovations Group plc Appoints Robert Easton as Independent Non-Executive Director, Effective August 1, 2015

Imperial Innovations Group plc has announced the appointment of Dr. Robert Easton to the board as an independent non-executive director with effect from 1 August 2015, the start of the group's new financial year. Dr. Robert Easton is a Partner and Managing Director at The Carlyle Group. He is a veteran of the firm and has performed multiple roles as an investment professional, including running the buyout team in the UK, serving as co-head of Carlyle Europe Technology Partners. Prior to joining Carlyle in 2000, Dr. Easton was Vice President of Corporate Development at Invensys plc.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IVO:LN 482.50 GBp +12.50

IVO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Health Discovery Corp $0.03 USD 0.00
MDxHealth €3.75 EUR +0.07
Miraculins Inc C$0.05 CAD 0.00
Myriad Genetics Inc $39.19 USD -0.19
Vermillion Inc $2.10 USD +0.02
View Industry Companies

Industry Analysis


Industry Average

Valuation IVO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 133.3x
Price/Book 1.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 134.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMPERIAL INNOVATIONS GROUP P, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at